Media Center
-
The U.S. Food and Drug Administration Approves Epcoritamab-bysp (Epkinly) for Diffuse Large B-Cell Lymphoma
On May 19, 2023 the U.S. Food and Drug Administration (FDA) announced it has approved…
-
Lymphoma Research Foundation Funds 27 New Grants Supporting the Next Generation of Lymphoma Scientists
Lymphoma Research Foundation Awards More Than $5.4 Million in Lymphoma Research Grants New York, NY…
-
The U.S. Food and Drug Administration Approves Polatuzumab Vedotin-piiq (Polivy) for Diffuse Large B-Cell Lymphoma
On April 19, 2023 the U.S. Food and Drug Administration (FDA) announced it has approved polatuzumab…
-
Update on AbbVie Withdrawal of Accelerated Approvals for Mantle Cell Lymphoma and Marginal Zone Lymphoma Indications
On April 6, 2023, AbbVie announced its intent to withdraw the accelerated approval of ibrutinib…
-
Read the Latest Issue of Pulse: Winter 2023
Read the Spring 2022 edition of Pulse. This issue of Pulse introduces our 2022 Clinical Investigator Career Development Award (CDA) and Postdoctoral Fellowship and Follicular Lymphoma Priority Research Grantees.
MEDIA INQUIRIES:
We welcome members of the press to contact our Communications team at media@lymphoma.org with any media-related questions or interview requests.
